CRISPR-Lenti Human EMX1 Positive Control Transduction Particles

The Sigma CRISPR-LENTI HUMAN EMX1 POSITIVE CONTROL TRANSDUCTION PARTICLES are a critical positive control to monitor transduction efficiency for lenti CRISPRs. This control is produced from the sequence-verified CRISPR lentiviral plasmid targeting human EMX1. EMX1 is one of the members of the EMX homeobox family, which are expressed in the developing cerebrum and involved in specification of positional identity and neural cell proliferation. This targets a validated EMX1 CRISPR site, which serves as an experimental control for Sigma lenti CRISPRs. The Sigma lenti CRISPR positive control is a one-component system consisting of a EF1-alpha-driven Cas9, a U6-driven guide RNA plasmid targeting the human EMX1 gene, with both Puromycin and GFP co-expressed with Cas9.

Lentiviral-based particles permit efficient infection and integration of the construct into differentiated and non-dividing cells, such as neurons and dendritic cells, overcoming low transfection and integration difficulties when using these cell lines. Self-inactivating replication incompetent viral particles are produced in packaging cells (HEK293T) by co-transfection with compatible packaging plasmids.

功能性基因组学研究/筛选/靶标验证

• 阳性对照，CRISPR 慢病毒，病毒形式，用于在细胞系中进行基因敲除和基因修饰。

请访问sigma.com/crisprs，查看更多应用数据、实验方案和载体图谱。

使用lenti CRISPR（病毒形式），作为CRISPR编辑工作流程的阳性实验对照。利用CRSIPR/Cas9系统对您的系统进行验证。错误匹配检测试验的阳性结果将表明您的系统是有效的。

200 μl of 10⁶ TU/ml (via p24 titering assay) lentiviral particles are provided as frozen stock.

CRISPR专利正在申请中